• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对群组随机试验以及在个体和群组层面都有结局的群组实施治疗的优化设计。

Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level.

作者信息

Moerbeek Mirjam

机构信息

Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands.

出版信息

Stat Methods Med Res. 2020 Mar;29(3):797-810. doi: 10.1177/0962280219846149. Epub 2019 May 1.

DOI:10.1177/0962280219846149
PMID:31041883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7082894/
Abstract

With group randomized trials complete groups of subject are randomized to treatment conditions. Such grouping also occurs in individually randomized trials where treatment is administered in groups. Outcomes may be measured at the level of the subject, but also at the level of the group. The optimal design determines the number of groups and the number of subjects per group in the intervention and control conditions. It is found by taking a budgetary constraint into account, where costs are associated with implementing the intervention and control, and with taking measurements on subject and groups. The optimal design is found such that the effect of treatment is estimated with highest efficiency, and the total costs do not exceed the budget that is available. The design that is optimal for the outcome at the subject level is not necessarily optimal for the outcome at the group level. Multiple-objective optimal designs consider both outcomes simultaneously. Their aim is to find a design that has high efficiencies for both outcome measures. An Internet application for finding the multiple-objective optimal design is demonstrated on the basis of an example from smoking prevention in primary education, and another example on consultation time in primary care.

摘要

在成组随机试验中,将受试对象分组并随机分配至各治疗条件。这种分组也会出现在个体随机试验中,即治疗以组为单位进行。结局可在个体水平进行测量,也可在组水平进行测量。最优设计确定了干预组和对照组的组数以及每组的受试对象数量。它是通过考虑预算限制得出的,其中成本与实施干预和对照以及对个体和组进行测量相关。找到最优设计是为了以最高效率估计治疗效果,且总成本不超过可用预算。在个体水平对结局最优的设计不一定在组水平对结局也是最优的。多目标最优设计同时考虑两种结局。其目的是找到一种对两种结局测量都具有高效率的设计。基于小学预防吸烟的一个例子以及初级保健中咨询时间的另一个例子,展示了一个用于寻找多目标最优设计的互联网应用程序。

相似文献

1
Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level.针对群组随机试验以及在个体和群组层面都有结局的群组实施治疗的优化设计。
Stat Methods Med Res. 2020 Mar;29(3):797-810. doi: 10.1177/0962280219846149. Epub 2019 May 1.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Optimal design of cluster randomized crossover trials with a continuous outcome: Optimal number of time periods and treatment switches under a fixed number of clusters or fixed budget.具有连续结局的群组随机交叉试验的最优设计:在固定数量的群组或固定预算下,最佳的时间段和治疗转换数量。
Behav Res Methods. 2024 Dec;56(8):8820-8830. doi: 10.3758/s13428-024-02505-1. Epub 2024 Sep 13.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Optimal placebo-treatment comparisons in trials with an incomplete within-subject design and heterogeneous costs and variances.在具有不完全个体内设计和异质成本和方差的试验中,最优安慰剂治疗比较。
PLoS One. 2023 Apr 20;18(4):e0283382. doi: 10.1371/journal.pone.0283382. eCollection 2023.
6
Optimal allocation to treatments in a sequential multiple assignment randomized trial.序贯多项分配随机试验中的最优治疗分配。
Stat Methods Med Res. 2021 Nov;30(11):2471-2484. doi: 10.1177/09622802211037066. Epub 2021 Sep 23.
7
Dynamic wait-listed designs for randomized trials: new designs for prevention of youth suicide.随机试验的动态候补名单设计:预防青少年自杀的新设计
Clin Trials. 2006;3(3):259-71. doi: 10.1191/1740774506cn152oa.
8
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述:观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.基于互联网的电子学习对临床医生行为和患者结局的有效性:一项系统评价方案。
JBI Database System Rev Implement Rep. 2015 Jan;13(1):52-64. doi: 10.11124/jbisrir-2015-1919.

引用本文的文献

1
Optimal study designs for cluster randomised trials: An overview of methods and results.最优的群组随机对照试验设计:方法和结果概述。
Stat Methods Med Res. 2023 Nov;32(11):2135-2157. doi: 10.1177/09622802231202379. Epub 2023 Oct 6.
2
Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity.最大最小最优区组随机设计评估治疗效应异质性。
Stat Med. 2023 Sep 20;42(21):3764-3785. doi: 10.1002/sim.9830. Epub 2023 Jun 20.
3
Optimal allocation to treatments in a sequential multiple assignment randomized trial.

本文引用的文献

1
International variations in primary care physician consultation time: a systematic review of 67 countries.初级保健医生会诊时间的国际差异:对67个国家的系统评价
BMJ Open. 2017 Nov 8;7(10):e017902. doi: 10.1136/bmjopen-2017-017902.
2
Investigating the relationship between consultation length and patient experience: a cross-sectional study in primary care.探讨会诊时长与患者体验之间的关系:一项初级医疗保健领域的横断面研究。
Br J Gen Pract. 2016 Dec;66(653):e896-e903. doi: 10.3399/bjgp16X687733. Epub 2016 Oct 24.
3
Efficient treatment allocation in 2 × 2 cluster randomized trials, when costs and variances are heterogeneous.
序贯多项分配随机试验中的最优治疗分配。
Stat Methods Med Res. 2021 Nov;30(11):2471-2484. doi: 10.1177/09622802211037066. Epub 2021 Sep 23.
在成本和方差存在异质性的2×2整群随机试验中进行有效的治疗分配
Stat Med. 2016 Oct 30;35(24):4320-4334. doi: 10.1002/sim.7003. Epub 2016 Jun 7.
4
Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.固定聚类大小以及类内相关性和方差均不同的随机试验中治疗效果的样本量计算。
Stat Methods Med Res. 2015 Oct;24(5):557-73. doi: 10.1177/0962280214563100. Epub 2014 Dec 17.
5
Cluster randomized trials for health care quality improvement research.用于医疗质量改进研究的整群随机试验。
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S31-7. doi: 10.1016/j.acap.2013.07.008.
6
Consort 2010 statement: extension to cluster randomised trials.《CONSORT 2010声明:群组随机试验扩展版》
BMJ. 2012 Sep 4;345:e5661. doi: 10.1136/bmj.e5661.
7
Efficiency loss due to varying cluster sizes in cluster randomized trials and how to compensate for it: comment on You et al. (2011).整群随机试验中因群大小不同导致的效率损失及其补偿方法:对You等人(2011年)的评论
Clin Trials. 2012 Feb;9(1):125; author reply 126-7. doi: 10.1177/1740774511428649.
8
Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity.心理治疗随机试验中的治疗师变异性:对精度、内部和外部有效性的影响。
Stat Methods Med Res. 2010 Jun;19(3):291-315. doi: 10.1177/0962280209105017. Epub 2009 Jul 16.
9
Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.个体随机分组治疗试验:对常用设计和分析方法的批判性评价
Am J Public Health. 2008 Aug;98(8):1418-24. doi: 10.2105/AJPH.2007.127027. Epub 2008 Jun 12.
10
Sample size formulae for trials comparing group and individual treatments in a multilevel model.用于在多水平模型中比较组治疗和个体治疗的试验的样本量公式。
Stat Med. 2008 Jul 10;27(15):2850-64. doi: 10.1002/sim.3115.